NYSE AMERICAN UPLISTING....so typical and other interested parties....there is only two reasons why HEXO and any other company wants to go to the time and expense of listing on multiple markets.
EQUITY AND EXPOSURE. Even being listed to the junior side of the NYSE in itself will provide (over time) the exposure that HEXO will require to fill its bank account for the increased need of capital as it grows into a multinational consumer product company. Phase 2 of legalization in the Canadian market is just the very first step that must be financed through additional shares being allocated, as the initial revenue stream will be behind and below the capitalization of these new ventures. JV, means HEXO will be responsible for its part of the capital needed to enter each new market. TRUSS, VEAPES, COSMETICS etc....and future expansion plans into Europe, South America, USA.
All these steps, for the most part have been financed by other MJ companies by the same issuance of shares. The one major exception being the equity stake held by Constellation Brands in Canopy.
IMHO,....I would much prefer a takeover by Molsons/Conor’s or a very large equity stake by big pharma and or big tobacco then running up the outstanding shares. This may very well be in Hexos future, hard to say. The significance of the shelf prospectus should not be taken lightly.
Lots of interesting chess moves to be made.